Related references
Note: Only part of the references are listed.SIMVASTATIN-MEDIATED ENHANCEMENT OF LONG-TERM POTENTIATION IS DRIVEN BY FARNESYL-PYROPHOSPHATE DEPLETION AND INHIBITION OF FARNESYLATION
R. A. Mans et al.
NEUROSCIENCE (2012)
Cholesterol Level and Statin Use in Alzheimer Disease I. Review of Epidemiological and Preclinical Studies
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Cholesterol Level and Statin Use in Alzheimer Disease II. Review of Human Trials and Recommendations
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Biochemical and molecular mechanisms of action of bisphosphonates
Michael J. Rogers et al.
BONE (2011)
Pitavastatin Calcium: Clinical Review of a New Antihyperlipidemic Medication
Laurie L. Yee et al.
CLINICAL THERAPEUTICS (2011)
The Early Involvement of the Innate Immunity in the Pathogenesis of Late-onset Alzheimer's Disease: Neuropathological, Epidemiological and Genetic Evidence
P. Eikelenboom et al.
CURRENT ALZHEIMER RESEARCH (2011)
The Role of Rho GTPase Proteins in CNS Neuronal Migration
Eve-Ellen Govek et al.
DEVELOPMENTAL NEUROBIOLOGY (2011)
The three new pathways leading to Alzheimer's disease
K. Morgan
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Control of synapse development and plasticity by Rho GTPase regulatory proteins
Kimberley F. Tolias et al.
PROGRESS IN NEUROBIOLOGY (2011)
Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats
Tessa N. Douma et al.
PSYCHOPHARMACOLOGY (2011)
Targeting protein prenylation for cancer therapy
Norbert Berndt et al.
NATURE REVIEWS CANCER (2011)
Progeria, the nucleolus and farnesyltransferase inhibitors
Ishita S. Mehta et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: Synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator
Paul A. Lapchak et al.
BRAIN RESEARCH (2010)
Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations
Jinghong Kou et al.
BRAIN RESEARCH (2010)
Evaluation of Alkyne-Modified Isoprenoids as Chemical Reporters of Protein Prenylation
Amanda J. DeGraw et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
A. J. Roelofs et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Farnesyltransferase inhibitors: where are we now?
Apostolia Maria Tsimberidou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
Mitsuru Shinohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p120 Catenin/αN-Catenin Are Molecular Targets in the Neuroprotection and Neuronal Plasticity Mediated by Atorvastatin After Focal Cerebral Ischemia
Angel Cespedes-Rubio et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
A Tagging-via-substrate Approach to Detect the Farnesylated Proteome Using Two-dimensional Electrophoresis Coupled with Western Blotting
Fredrick O. Onono et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Modulation of Cholesterol, Farnesylpyrophosphate, and Geranylgeranylpyrophosphate in Neuroblastoma SH-SY5Y-APP695 Cells: Impact on Amyloid Beta-Protein Production
Gero P. Hooff et al.
MOLECULAR NEUROBIOLOGY (2010)
The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
Chun-Ki Kim et al.
MOLECULAR PHARMACOLOGY (2010)
Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles?
Stacey Fuller et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery
Wolfgang Jahnke et al.
NATURE CHEMICAL BIOLOGY (2010)
Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner
Madhuvanthi Kannan et al.
NEUROBIOLOGY OF AGING (2010)
Inflammation, microglia, and alzheimer's disease
Brent Cameron et al.
NEUROBIOLOGY OF DISEASE (2010)
Small G Protein Signaling in Neuronal Plasticity and Memory Formation: The Specific Role of Ras Family Proteins
Xiaojing Ye et al.
NEURON (2010)
SIMVASTATIN ENHANCES HIPPOCAMPAL LONG-TERM POTENTIATION IN C57BL/6 MICE
R. A. Mans et al.
NEUROSCIENCE (2010)
Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer
Meng Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A novel approach to tag and identify geranylgeranylated proteins
Lai N. Chan et al.
ELECTROPHORESIS (2009)
Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
Anamitra Ghosh et al.
JOURNAL OF NEUROSCIENCE (2009)
Analysis of the eukaryotic prenylome by isoprenoid affinity tagging
Uyen T. T. Nguyen et al.
NATURE CHEMICAL BIOLOGY (2009)
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients
Gunter P. Eckert et al.
NEUROBIOLOGY OF DISEASE (2009)
Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease
Zhihua Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain)
Manuel Fernandez Martinez et al.
BMC NEUROLOGY (2008)
Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of A beta and APP-CTF gamma
Yan Zhou et al.
FASEB JOURNAL (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury
Hongtao Wu et al.
JOURNAL OF NEUROTRAUMA (2008)
Inhibition of Rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis
Ajaib Singh Paintlia et al.
MOLECULAR PHARMACOLOGY (2008)
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
Ignacio Varela et al.
NATURE MEDICINE (2008)
Essential Role of TGF-β/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation
Juan Rodriguez-Vita et al.
PLOS ONE (2008)
Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation
Tiina Kotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
Brian C. Capell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2
Ruixia Xu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Statins reduce amyloid-β production through inhibition of protein Isoprenylation
Stephen M. Ostrowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury
Haichen Wang et al.
EXPERIMENTAL NEUROLOGY (2007)
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury
Dunyue Lu et al.
JOURNAL OF NEUROTRAUMA (2007)
Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals
Dolores Perez-Sala
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Towards complete sets of farnesylated and geranylgeranylated proteins
Sebastian Maurer-Stroh et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging
Thomas Dechat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Lovastatin protects human neurons against Aβ-induced toxicity and causes activation of β-catenin-TCF/LEF signaling
Pradeep Salins et al.
NEUROSCIENCE LETTERS (2007)
Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment
Cornelia Franke et al.
NEUROBIOLOGY OF DISEASE (2007)
The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta(1-42) in the rat hippocampus in vivo
Rachael M. Clarke et al.
NEUROPHARMACOLOGY (2007)
Prelamin A farnesylation and progeroid syndromes
Stephen G. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Simvastatin enhances learning and memory independent of amyloid load in mice
Ling Li et al.
ANNALS OF NEUROLOGY (2006)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury
Eric Holmberg et al.
JOURNAL OF NEUROTRAUMA (2006)
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
Shao H. Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat
Jennifer M. Horwood et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs
Kathryn L. Kavanagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons
AM Pooler et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy
Chih-Tai Leu et al.
BONE (2006)
Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I
KT Lane et al.
JOURNAL OF LIPID RESEARCH (2006)
A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria
LG Fong et al.
SCIENCE (2006)
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
TJ Kotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Geranylgeranylation of Rab GTPases
KF Leung et al.
JOURNAL OF LIPID RESEARCH (2006)
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs
Jean-Michel Rondeau et al.
CHEMMEDCHEM (2006)
Isoprenylated proteins
SJ McTaggart
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo
A Kretz et al.
NEUROBIOLOGY OF DISEASE (2006)
Fighting parasitic disease by blocking protein farnesylation
RT Eastman et al.
JOURNAL OF LIPID RESEARCH (2006)
Intraneuronal β-amyloid expression downregulates the Akt survival pathway and blunts the stress response
J Magrané et al.
JOURNAL OF NEUROSCIENCE (2005)
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
WD Li et al.
CURRENT BIOLOGY (2005)
Mechanisms of statin-mediated inhibition of small G-protein function
A Cordle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effects of statins on microglia
C Lindberg et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
Rho GTPases, dendritic structure, and mental retardation
SE Newey et al.
JOURNAL OF NEUROBIOLOGY (2005)
Bisphosphonates and cancer-induced bone disease:: Beyond their antiresorptive activity
P Clézardin et al.
CANCER RESEARCH (2005)
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity
L Nallan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Statins cause intracellular accumulation of amyloid precursor protein, β-secretase-cleaved fragments, and amyloid β-peptide via an isoprenoid-dependent mechanism
SL Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Atorvastatin for the treatment of mild to moderate Alzheimer disease - Preliminary results
DL Sparks et al.
ARCHIVES OF NEUROLOGY (2005)
Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production
BS Zuckerbraun et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Statins -: a cure-all for the brain?
T Menge et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones
J Bösel et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex
LN Johnson-Anuna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors attenuate β-amyloid-induced microglial inflammatory responses
A Cordle et al.
JOURNAL OF NEUROSCIENCE (2005)
Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK
S Pedrini et al.
PLOS MEDICINE (2005)
HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis
JG Schulz et al.
JOURNAL OF NEUROCHEMISTRY (2004)
A tagging-via-substrate technology for detection and proteomics of farnesylated proteins
Y Kho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability
D Carrico et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Rosuvastatin reduces caspase-3 activity and up-regulates α-secretase in human neuroblastoma SH-SY5Y cells exposed to Aβ
D Famer et al.
NEUROSCIENCE LETTERS (2004)
Mitogen-activated protein kinases in synaptic plasticity and memory
JD Sweatt
CURRENT OPINION IN NEUROBIOLOGY (2004)
Lovastatin modulation of microglial activation via suppression of functional CD40 expression
KP Townsend et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity
PT Pang et al.
SCIENCE (2004)
Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity
TS Reid et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
T Vollmer et al.
LANCET (2004)
Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1β and tumor necrosis factor-α mRNA induction, and does not affect endothelial nitric oxide synthase expression
W Balduini et al.
STROKE (2003)
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
MA Pappolla et al.
NEUROLOGY (2003)
Statin-associated memory loss: Analysis of 60 case reports and review of the literature
LR Wagstaff et al.
PHARMACOTHERAPY (2003)
The inhibition of Ras farnesylation leads to an increase in p27Kip1 and G1 cell cycle arrest
H Reuveni et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity
C Thornton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
JL Chen et al.
ANNALS OF NEUROLOGY (2003)
Prevention of stroke and dementia with statins: Effects beyond lipid lowering
CJ Vaughan
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Aβ1-42 in glioma cell culture in vitro
YX Sun et al.
PHARMACOLOGICAL RESEARCH (2003)
Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease
V Meske et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer's brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants
JR Fawcett et al.
BRAIN RESEARCH (2002)
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease:: A 26-week randomized, placebo-controlled, double-blind trial
M Simons et al.
ANNALS OF NEUROLOGY (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
The farnesyltransferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status
NC Crespo et al.
CELL DEATH AND DIFFERENTIATION (2002)
NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1
R Yaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
RM Costa et al.
NATURE (2002)
Short-term local delivery of an inhibitor of ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty
LM Work et al.
CIRCULATION (2001)
A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala
CH Lin et al.
NEURON (2001)
The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells
NC Crespo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
E Kojro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298
FP Coxon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
HMG-CoA reductase inhibitors and the risk of fractures
CR Meier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Neuroscience - Memory - a century of consolidation
JL McGaugh
SCIENCE (2000)
Share Paper
